The second-generation GEMMs were born in 1997 with the Mt-PRL [42], a mouse model created to further study the role of prolactin (PRL) in prostate hyperplasia; the PRL ectopic expression has been inducted by Metallothionein-1 (Mt-1) promoter. Here, MT1A is linked to hyperplasia.